Top Markets
Coin of the day
Qlife Holding AB (publ) Qlife Holding AB (publ)

Qlife Holding AB (publ)

QLIFE
Rang in Aktien #36577
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in... Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
Aktienkurs
$0.20529272
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$2.54M
Veränderung (1 Tag)
0.11%
Veränderung (1 Jahr)
-49.29%
Land
SE
Handel Qlife Holding AB (publ) (QLIFE)

Kategorie

Dividendenrendite-Verlauf für Qlife Holding AB (publ) (QLIFE)
Dividendenrendite (TTM) von Qlife Holding AB (publ) (Aktienkürzel: QLIFE) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Qlife Holding AB (publ) (QLIFE) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber